Galectin Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.0k | 1.8k | 1.66 |
| 2023-09-30 | $178 | 93 | 1.92 |
| 2023-06-30 | $62 | 43 | 1.44 |
| 2023-03-31 | $0 | 43 | 0.00 |
| 2022-12-31 | $0 | 43 | 0.00 |
| 2022-06-30 | $0 | 43 | 0.00 |
| 2022-03-31 | $0 | 43 | 0.00 |
| 2021-12-31 | $0 | 43 | 0.00 |
| 2021-03-31 | $216k | 101k | 2.15 |
| 2020-12-31 | $232k | 104k | 2.24 |
| 2020-09-30 | $72k | 22k | 3.32 |
| 2020-06-30 | $85k | 28k | 3.04 |
| 2020-03-31 | $79k | 41k | 1.95 |
| 2019-12-31 | $38k | 13k | 2.89 |
| 2019-09-30 | $48k | 13k | 3.66 |
| 2019-06-30 | $40k | 10k | 3.91 |
| 2019-03-31 | $964k | 189k | 5.11 |
| 2014-03-31 | $165k | 11k | 15.36 |